Interferon alpha-2b biosimilar (Laboratorio Varifarma)

干扰素α-2b生物类似药 (Laboratorio Varifarma)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alpha-2b biosimilar (Laboratorio Varifarma)
Drug Alias Name干扰素α-2b生物仿制药 (Laboratorio Varifarma)Interferon alfa 2b Cassara
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsNeoplasmsHepatitis CHepatitis B +[4] 
Global Approved IndicationsNeoplasmsHepatitis CHepatitis B +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryArgentina
Original Approved Date2014/01/01
Country/TerritoryArgentina
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratorio Varifarma
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorio Varifarma
Inactive CompaniesN/A
Active IndicationsNeoplasmsHepatitis CHepatitis B +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A